Dendritic Poly( l -lysine)-Based Nanoparticle Loading with siDNMT1 to Alleviate Basal Cell Carcinoma Progression by Inhibiting Methylation of AXIN2
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c00802 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Siying Xiong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, Guangdong 510095, China. Hauptthemen laut MEDLINE: Nanoparticles, Polylysine, Basal Cell Carcinoma, Axin Protein. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, Guangdong 510095, China.
- Department of Laser Cosmetology, Foshan Fosun Chanchiang Hospital, Foshan, Guangdong 528000, China.
ORCID-Profile: Aili Gao
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Xiong, S., Wang, X., Yang, Y., Gan, Y., & Gao, A. (2025). Dendritic Poly( l -lysine)-Based Nanoparticle Loading with siDNMT1 to Alleviate Basal Cell Carcinoma Progression by Inhibiting Methylation of AXIN2. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c00802
Vancouver
Xiong S, Wang X, Yang Y, Gan Y, Gao A. Dendritic Poly( l -lysine)-Based Nanoparticle Loading with siDNMT1 to Alleviate Basal Cell Carcinoma Progression by Inhibiting Methylation of AXIN2. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c00802
BibTeX
@article{Xiong2025,
author = {Xiong, Siying and Wang, Xue and Yang, Yan and Gan, Yizhuan and Gao, Aili},
title = {Dendritic Poly( l -lysine)-Based Nanoparticle Loading with siDNMT1 to Alleviate Basal Cell Carcinoma Progression by Inhibiting Methylation of AXIN2},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c00802}
}
EUVIMED